Egis Rompharma SRL

EGIS ROMPHARMA SRL

ROIndustrialsCUI 19009329CAEN 4646Cluj-Napoca, Cluj57 employees (2025 average)

Investment brief

Investment brief: Egis Rompharma SRL

Create a free account to read 3 full briefs a month: verdict, strengths, risks, how you could invest and what the price implies. No card needed.

Founding members

The first 100 accounts get 3 months free

98 of 100 free places left · 2 taken

Create your account and get full access for 3 months — no card, no automatic charge. After that it is 20 € a month, only if you choose to continue.

Create a free account

Already have an account? Sign in

Key figures · FY2025

Revenue
RON 242.6m
Growth
+11%
Net income
RON 5.17m
Net margin
2.1%
Cash
RON 12.17m
Equity
RON 14.2m
Employees (average)
57

Four-year trend

Revenue
2024: RON 218.52mRON 218.52m20242025: RON 242.6mRON 242.6m2025
Net income
2024: RON 5.8mRON 5.8m20242025: RON 5.17mRON 5.17m2025

Annual figures as filed with the Ministry of Finance for the two latest fiscal years; growth computed in code. Source: data.gov.ro, Situații financiare (CC BY 4.0).

Place in every ranking

This company is not in the rankings (they cover companies with at least USD 1 bn in revenue).

Figures for FY2025 (year ending 2025-12-31) from the company's annual financial statements as filed with the Romanian Ministry of Finance (open data on data.gov.ro, CC BY 4.0), in RON. Net turnover (I13), net result (I18 − I19), cash (I5) and equity (I10) as filed; growth and margins computed in code. Operating result and cash flow are not in that data. These lists rank companies by reported figures. A high rank is a fact about the numbers, not a recommendation to buy, sell or hold, and not personalised advice. Past results do not predict future returns.

Find a company